These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33577917)

  • 1. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.
    Ge S; Zhang Q; Chen Y; Tian Y; Yang R; Chen X; Li F; Zhang B
    Toxicol Appl Pharmacol; 2021 Mar; 415():115450. PubMed ID: 33577917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
    Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
    Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 5. Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5.
    Tian Y; Yang W; Yang R; Zhang Q; Hao L; Bian E; Yang Y; Huang X; Wu Y; Zhang B
    Toxicol Appl Pharmacol; 2022 Jan; 435():115829. PubMed ID: 34919946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of PRMT5 by AMI-1 enhances therapeutic efficacy of compound kushen injection in lung carcinoma in vitro and in vivo.
    Yang R; Dong S; Zhang J; Zhu S; Miao G; Zhang B
    Mol Cell Biochem; 2023 May; 478(5):1031-1044. PubMed ID: 36214894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression.
    Demetriadou C; Pavlou D; Mpekris F; Achilleos C; Stylianopoulos T; Zaravinos A; Papageorgis P; Kirmizis A
    Cell Death Dis; 2019 Mar; 10(3):236. PubMed ID: 30858358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell metabolic profiling of colorectal cancer via
    Ge S; Zhang Q; Tian Y; Hao L; Duan J; Zhang B
    Clin Chim Acta; 2020 Nov; 510():291-297. PubMed ID: 32707041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRMT5 promotes colorectal cancer growth by interaction with MCM7.
    Li X; Wang X; Zhao J; Wang J; Wu J
    J Cell Mol Med; 2021 Apr; 25(7):3537-3547. PubMed ID: 33675123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
    Saha K; Adhikary G; Eckert RL
    J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
    Hartley AV; Wang B; Mundade R; Jiang G; Sun M; Wei H; Sun S; Liu Y; Lu T
    Sci Rep; 2020 Sep; 10(1):15934. PubMed ID: 32985589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
    Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
    Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies.
    Abumustafa W; Zamer BA; Khalil BA; Hamad M; Maghazachi AA; Muhammad JS
    Biomed Pharmacother; 2022 Jan; 145():112368. PubMed ID: 34794114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin.
    Cai S; Wang P; Xie T; Li Z; Li J; Lan R; Ding Y; Lu J; Ye J; Wang J; Li Z; Liu P
    Pharmacol Res; 2020 Nov; 161():105104. PubMed ID: 32739429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma.
    Cao J; Sun X; Zhang X; Chen D
    Clin Transl Oncol; 2018 Jun; 20(6):761-767. PubMed ID: 29086249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin inhibits cell proliferation and metastasis and prolongs survival in soft tissue sarcomas by downregulating both protein arginine methyltransferases 1 and 5.
    Zhang Q; Yang R; Tian Y; Ge S; Nan X; Zhu S; Dong S; Zhang B
    Basic Clin Pharmacol Toxicol; 2022 Jul; 131(1):18-33. PubMed ID: 35470570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
    Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
    Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.